Back to Sumitomo Mitsui Trust Group, Inc. Sumitomo Mitsui Trust Group, Inc.

CRSPCRSP
18 quarters

Position history for Sumitomo Mitsui Trust Group, Inc.Sumitomo Mitsui Trust Group, Inc.'s holdings in CRISPR THERAPEUTICS AG

Yes. Sumitomo Mitsui Trust Group holds 1,720,734 shares of CRSP (Crispr Therapeutics), worth $93.8M, as of its Q2 2026 13F filing. It reduced the position by 133,141 shares (-7.2%) from Q1 2026. Sumitomo Mitsui Trust Group has held CRSP since Q1 2022, across 18 quarterly 13F filings. CRSP is 0.1% of Sumitomo Mitsui Trust Group's reported 13F portfolio.

Current Value

$93.8M

Current Shares

1.7M

Total Value Change

-$196.1M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-7.2%
$93.8M0.1%$54.54
0
2026-Q1
Decreased
1.9M
-5.3%
$88.2M0.1%$47.57
0
2025-Q4
Decreased
2M
-9.5%
$102.7M0.1%$52.44
0
2025-Q3
Decreased
2.2M
-10.4%
$140.2M0.1%$64.81
0
2025-Q2
Decreased
2.4M
-4.9%
$117.5M0.1%$48.64
0
2025-Q1
Decreased
2.5M
-7.5%
$86.4M0.1%$34.03
0
2024-Q4
Decreased
2.7M
-7.5%
$108.1M0.1%$39.36
0
2024-Q3
Decreased
3M
-5.8%
$139.4M0.1%$46.98
0
2024-Q2
Decreased
3.2M
-3.6%
$170.2M0.1%$54.01
0
2024-Q1
Decreased
3.3M
-3.0%
$222.8M0.2%$68.16
0
2023-Q4
Decreased
3.4M
-2.8%
$210.9M0.2%$62.60
0
2023-Q3
Decreased
3.5M
-1.9%
$157.3M0.1%$45.39
0
2023-Q2
Decreased
3.5M
-11.1%
$198.4M0.2%$56.14
0
2023-Q1
Decreased
4M
-0.8%
$179.7M0.1%$45.23
0
2022-Q4
Decreased
4M
-6.0%
$162.9M0.1%$40.65
0
2022-Q3
Decreased
4.3M
-7.0%
$278.6M0.2%$65.35
0
2022-Q2
Decreased
4.6M
-0.8%
$278.6M0.2%$60.77
0
2022-Q1
New
4.6M
-
$290M0.2%$62.77
51

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used